J. P. van Tintelen

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

A. Wilde, R. D. de Boer, F. Asselbergs, 2021, Netherlands Heart Journal.

High Distress in Parents Whose Children Undergo Predictive Testing for Long QT Syndrome

A. Wilde, J. van den Bout, I. V. van Langen, 2005, Public Health Genomics.

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update

R. Hauer, A. Wilde, K. Zeppenfeld, 2019, Netherlands Heart Journal.

Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the Netherlands

L. Vissers, R. Pfundt, R. V. van Lingen, 2023, European Journal of Pediatrics.

UNRAVEL: big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking

H. Kirkels, F. Asselbergs, A. Baas, 2019, Netherlands Heart Journal.

Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia.

R. Hauer, M. P. van den Berg, R. Hofstra, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Can parents adjust to the idea that their child is at risk for a sudden death?: Psychological impact of risk for long QT syndrome

J. van den Bout, I. V. van Langen, J. P. van Tintelen, 2005, American journal of medical genetics. Part A.

Founder mutations in inherited cardiac diseases in the Netherlands

A. Wilde, J. P. van Tintelen, J. Jongbloed, 2014, Bohn Stafleu van Loghum.

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

R. D. de Boer, A. Baas, J. Jans, 2023, Journal of cardiovascular translational research.